RUNBEN BIOTECHNOLOGY financial statements, including revenue, expenses, profit, and loss

The total revenue of 603193 for the last quarter is 290.58 M CNY, and it's 49.14% lower compared to the previous quarter. The net income of Q3 24 is 80.86 M CNY.